Roy M. Robins‐Browne

23.4k total citations · 3 hit papers
289 papers, 13.8k citations indexed

About

Roy M. Robins‐Browne is a scholar working on Infectious Diseases, Endocrinology and Genetics. According to data from OpenAlex, Roy M. Robins‐Browne has authored 289 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Infectious Diseases, 112 papers in Endocrinology and 75 papers in Genetics. Recurrent topics in Roy M. Robins‐Browne's work include Escherichia coli research studies (97 papers), Viral gastroenteritis research and epidemiology (77 papers) and Yersinia bacterium, plague, ectoparasites research (45 papers). Roy M. Robins‐Browne is often cited by papers focused on Escherichia coli research studies (97 papers), Viral gastroenteritis research and epidemiology (77 papers) and Yersinia bacterium, plague, ectoparasites research (45 papers). Roy M. Robins‐Browne collaborates with scholars based in Australia, United States and United Kingdom. Roy M. Robins‐Browne's co-authors include Myron M. Levine, Marija Tauschek, Elizabeth L. Hartland, Mimi L.K. Tang, Robert Boyle, Vicki Bennett‐Wood, Nigel Curtis, Juliana Kaya Prpic, James B. Kaper and Pablo Vial and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Roy M. Robins‐Browne

284 papers receiving 13.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Probiotic use in clinical practice: what are the risks?

2006 545 citations Robert Boyle, Roy M. Robins‐Browne et al. profile →
Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells

1987 510 citations Roy M. Robins‐Browne, Myron M. Levine et al. profile →
Emergence of Multiply Resistant Pneumococci

1978 493 citations Roy M. Robins‐Browne et al. profile →

Peers

Countries citing papers authored by Roy M. Robins‐Browne

Since Specialization

Citations

This map shows the geographic impact of Roy M. Robins‐Browne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy M. Robins‐Browne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy M. Robins‐Browne more than expected).

Fields of papers citing papers by Roy M. Robins‐Browne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy M. Robins‐Browne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy M. Robins‐Browne. The network helps show where Roy M. Robins‐Browne may publish in the future.

Co-authorship network of co-authors of Roy M. Robins‐Browne

This figure shows the co-authorship network connecting the top 25 collaborators of Roy M. Robins‐Browne. A scholar is included among the top collaborators of Roy M. Robins‐Browne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy M. Robins‐Browne. Roy M. Robins‐Browne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neonatal BCG vaccination to prevent asthma: Results from the MIS BAIR randomized controlled trial 2025 ·Pediatric Allergy and Immunology ·Laure F. Pittet, Emily K. Forbes, Susan Donath, Kate Francis, Kaya Gardiner, Katie L. Flanagan, Anne‐Louise Ponsonby, Roy M. Robins‐Browne, Frank Shann, Mike South, Peter Vuillermin, Dan Casalaz, Nigel Curtis, Nicole L. Messina, (unknown)	1
2	Immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density and shedding, and middle ear infection in mice 2024 ·Vaccine ·(unknown), Sam Manna, Eileen M. Dunne, (unknown), Casey L. Pell, Natalie L. Patterson, (unknown), Poshmaal Dhar, David Goldblatt, Kim Mulholland, Paul V. Licciardi, Roy M. Robins‐Browne, Richard Malley, Odilia Wijburg, Catherine Satzke	1
3	Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial 2022 ·American Journal of Respiratory and Critical Care Medicine ·Laure F. Pittet, (unknown), Marc Tebruegge, Binita Dutta, Susan Donath, Nicole L. Messina, Dan Casalaz, Willem A. Hanekom, Warwick J. Britton, Roy M. Robins‐Browne, Nigel Curtis, Nicole Ritz	6
4	Defeating the Ministers of Death. The Compelling History of Vaccination 2020 ·Microbiology Australia ·Roy M. Robins‐Browne	2
5	Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting 2018 ·Tuberculosis ·Vanessa Clifford, Marc Tebruegge, Christel Zufferey, Susie Germano, Ben Forbes, (unknown), Elizabeth Matchett, Emma S. McBryde, Damon P. Eisen, Roy M. Robins‐Browne, Alan Street, Justin T. Denholm, Nigel Curtis	37
6	The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children 2018 ·BMJ Open ·Claire S. Waddington, Charlie McLeod, Peter S Morris, Asha C Bowen, Mark Naunton, Jonathan R. Carapetis, Keith Grimwood, Roy M. Robins‐Browne, Carl D. Kirkwood, Rob Baird, David Green, Ross Andrews, (unknown), Joshua Francis, Julie Marsh, Tom Snelling	15
7	Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis 2017 ·Journal of Infection ·Vanessa Clifford, Marc Tebruegge, Christel Zufferey, Susie Germano, (unknown), (unknown), Emma S. McBryde, Damon P. Eisen, Roy M. Robins‐Browne, Alan Street, Justin T. Denholm, Nigel Curtis	17
8	In silico serotyping of E. coli from short read data identifies limited novel O-loci but extensive diversity of O:H serotype combinations within and between pathogenic lineages 2016 ·Microbial Genomics ·Danielle J. Ingle, Mary Valcanis, (unknown), Marija Tauschek, Michael Inouye, Timothy P. Stinear, Myron M. Levine, Roy M. Robins‐Browne, Kathryn E. Holt	146
9	Site of fluorescent label modifies interaction of melittin with live cells and model membranes 2015 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Elaheh Jamasbi, Giuseppe D. Ciccotosto, Julien Tailhades, Roy M. Robins‐Browne, (unknown), Robyn A. Sharples, Nitin A. Patil, John D. Wade, Mohammed Akhter Hossain, Frances Separovic	15
10	Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial 2010 ·Allergy ·Robert Boyle, Intan Hakimah Ismail, S. Kivivuori, Paul V. Licciardi, Roy M. Robins‐Browne, (unknown), (unknown), Sophie E. Moore, Susan Donath, John B. Carlin, Sampo J. Lahtinen, Mimi L.K. Tang	168
11	Characterisation of Shiga toxin-producing Escherichia coliO157 strains isolated from humans in Argentina, Australia and New Zealand 2008 ·BMC Microbiology ·Gerardo A. Leotta, Elizabeth Miliwebsky, Isabel Chinen, (unknown), Kristy Azzopardi, Sharon M. Tennant, Roy M. Robins‐Browne, Marta Rivas	59
12	Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli 2002 ·Proceedings of the National Academy of Sciences ·Marija Tauschek, Rebecca J. Gorrell, Richard A. Strugnell, Roy M. Robins‐Browne	128
13	Detection of a Widespread Clone of Pseudomonas aeruginosa in a Pediatric Cystic Fibrosis Clinic 2002 ·American Journal of Respiratory and Critical Care Medicine ·David Armstrong, Gillian M. Nixon, Rosemary Carzino, (unknown), John B. Carlin, Roy M. Robins‐Browne, Keith Grimwood	144
14	Examination ofSerpulina pilosicolifor attachment and invasion determinants of Enterobacteria 1998 ·FEMS Microbiology Letters ·Elizabeth L. Hartland, Andrew S. J. Mikosza, Roy M. Robins‐Browne, D.J. Hampson	6
15	Enteropathogenic Escherichia coli-associated infections in rabbits - A model of human infection 1996 ·Revista de Microbiologia ·Roy M. Robins‐Browne, (unknown), (unknown), Vicki Bennett‐Wood	2
16	Cochlear implants in children: the value of cochleostomy seals in the prevention of labyrinthitis following pneumococcal otitis media 1995 ·Australian Journal of Otolaryngology ·Markus Dahm, R. L. Webb, Graeme M. Clark, Burkhard Franz, Robert K. Shepherd, Martin J Burton, Roy M. Robins‐Browne	1
17	Enteropathogenic Escherichia coli enteritis: evaluation of the gnotobiotic piglet as a model of human infection. 1985 ·Gut ·Saul Tzipori, Roy M. Robins‐Browne, Gena Gonis, J S Hayes, (unknown), Εlinor ΜcCartney	96
18	A fimbrial antigen mediating haemagglutination ofEscherichia colifrom children 1982 ·FEMS Microbiology Letters ·D. C. A. Candy, (unknown), Robert H. Mak, (unknown), W. C. Marshall, Alan D. Phillips, Roy M. Robins‐Browne, Maureen V. Chadwick, Myron M. Levine	3
19	ESCHERICHIA-COLI GASTROENTERITIS IN ADULTS 1978 ·South African Medical Journal ·Roy M. Robins‐Browne, (unknown), (unknown)	2
20	Trypanosomiasis in Southern Africa with particular reference to cases seen in Johannesburg. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·J Schneider, (unknown), Lisbeth Clausen, Roy M. Robins‐Browne	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact